Boston Scientific (BSX): insider & executive buying
Boston Scientific · Health Care · ref. ETF XLV · price $46.67
In short — 5 insiders bought Boston Scientific over ~6 months (8 buys, total $10.0M, latest Aug 25, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Boston Scientific's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$46.67-55.9% over range
Aug 28, 25low $42.63 · high $108.14Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 22 analysts
Latest insider buys on Boston Scientific
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Aug 25, 26 | Morano Susan E | Dir | 2,040 | $100k |
| Aug 5, 26 | Habiger David C | Dir | 2,100 | $100k |
| Aug 3, 26 | Habiger David C | Dir | 1,182 | $57k |
| Aug 3, 26 | Mahoney Michael F | COB, Pres, CEO | 186,240 | $9.0M |
| Jul 31, 26 | Ludwig Edward J | Dir | 5,000 | $227k |
| May 20, 26 | Pegus Cheryl | Dir | 1,770 | $100k |
| May 20, 26 | Ludwig Edward J | Dir | 3,580 | $203k |
| May 19, 26 | Habiger David C | Dir | 4,450 | $251k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Boston Scientific's executives bought shares recently?
5 Boston Scientific insider(s) bought $10.0M over ~6 months (latest Aug 25, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for BSX?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Boston Scientific? The JPI assistant answers using our backtest data.